참고문헌
- Bellavite P, Andrioli G, Lussignoli S, Signorini A, Orto-lani R, Conforti A. A scientific reappraisal of the 'principle of similarity'. Med Hypotheses. 1997;49(3):203-12. https://doi.org/10.1016/S0306-9877(97)90204-8
- Bellavite P, Signorini A. The emerging science of homeopathy. Berkeley (CA): North Atlantic; 2002. 424 p.
- Teixeira MZ. 'Paradoxical strategy for treating chronic diseases': a therapeutic model used in homeopathy for more than two centuries, Homeopathy. 2005;94(4):265-6.
- Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev. 2006;35(7):583-92. https://doi.org/10.1039/b502142c
- Chikramane PS, Suresh AK, Bellare JR, Kane SG. Extreme homeopathic dilutions retain starting mate-rials: a nanoparticulate perspective. Homeopathy. 2010;99(4):231-42. https://doi.org/10.1016/j.homp.2010.05.006
- Sharma A, Purkait B. Identification of medicinally active ingredient in ultradiluted Digitalis purpurea: fluorescence spectroscopic and cyclic-voltammet-ric study. J Anal Methods Chem. 2012;2012:DOI: 10.1155/2012/109058.
- Bellavite P, Signorini A. The emerging science of homeopathy: complexity, biodynamics and nanopharma-cology. California: North Atlantic Books; 1995. 424 p.
- Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? a systematic review. Br Homeopath J. 2000;89(S1):S35-8. https://doi.org/10.1054/homp.1999.0378
- Posadzki P, Alotaibi A, Ernst E. Adverse effects of homeopathy: a systematic review of published case reports and case series. Int J Clin Pract. 2012;66(12):1178-88. https://doi.org/10.1111/ijcp.12026
- Vickers AJ. Independent replication of pre-clinical re-search in homoeopathy: a systematic review. Forsch Komplementarmed. 2004;6(6):311-20. https://doi.org/10.1159/000021286
- Barve R, Chaughule R. Size-dependent in vivo/in vitro results of homoeopathic herbal extracts. J Nanostruct Chem. 2013;3(1):18. https://doi.org/10.1186/2193-8865-3-18
- Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol. 2004;4(5):504-12. https://doi.org/10.1016/j.coph.2004.04.005
- Rubinstein AL. Zebrafish assays for drug toxicity screening. Expert Opin Drug Metab Toxicol. 2006;2(2):231-40. https://doi.org/10.1517/17425255.2.2.231
- Winter MJ, Redfern WS, Hayfield AJ, Owen SF, Valentin JP, Hutchinson TH. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods. 2008;57(3):176-87. https://doi.org/10.1016/j.vascn.2008.01.004
- Postlethwait JH, Woods IG, Ngo-Hazelett P, Yan YL, Kelly PD, Chu F, et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res. 2000;10(12):1890-902. https://doi.org/10.1101/gr.164800
- Redfern WS, Waldron G, Winter MJ, Butler P, Holbrook N, Wallis R, et al. Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring?. J Pharmacol Toxicol Methods. 2008;58(2):110-7. https://doi.org/10.1016/j.vascn.2008.05.006
- Parng C, Seng WL, Semino C, McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol. 2002;1(1):41-8. https://doi.org/10.1089/154065802761001293
- Ali S, van Mil HGJ, Richardson MK. Large-scale assessment of the zebrafish embryo as a possible predictive model in toxicity testing. Plos one. 2011;6(6):DOI: 10.1371/journal.pone.0021076.
- McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 2008;13(9-10):394-401. https://doi.org/10.1016/j.drudis.2008.03.002
- Bell IR, Muralidharan S, Schwartz GE. Nanoparti-cle characterization of traditional homeopathical-ly-manufactured silver (Argentum metallicum) medicines and placebo controls. J Nanomed Nanotechnol. 2015;6(4):DOI: 10.4172/2157-7439.1000311.
- Westerfield M. A guide for the laboratory use of zebraf-ish danio (brachydanio) rerio. Eugene:University of Oregon Press; 2000.
- Test no. 236: fish embryo acute toxicity (FET) test [internet]. OECD; 2013 [Nov, 2016]. Available from: http://www.oecd-ilibrary.org/docserver/down-load/9713161e.pdf?expires=1481098481&id=id&ac-cname=guest&checksum=0EFE0447C6B022B5CA-F2AAEB18B9F3CC.
- Hu YL, Qi W, Han F, Shao JZ, Gao JQ. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine. 2011;6:3351-9.
- Chikramane PS, Kalita D, Suresh AK, Kane SG, Bellare JR. Why extreme dilutions reach non-zero asymptotes: a nanoparticulate hypothesis based on froth flotation. Langmuir. 2012;28(45):15864-75. https://doi.org/10.1021/la303477s
- Upadhyay RP, Nayak C. Homeopathy emerging as na-nomedicine. International Journal of High Dilution Re-search. 2011;10(37):299-310.
- Demangeat JL. NMR relaxation evidence for sol-ute-induced nanosized superstructures in ultramo-lecular aqueous dilutions of silica-lactose. J Mol Liq. 2010;155(2-3):71-9. https://doi.org/10.1016/j.molliq.2010.05.010
- Rajendran ES. Field emission scanning electron microscopic (FESEM) and energy dispersive spectroscopic (EDS) studies of centesimal scale potencies of the homeopathic drug Lycopodium clavatum. AJHM. 2015;108(1):9-18.
- Konovalov A, Ryzhkina I. Highly diluted aqueous solutions: formation of nano-sized molecular assemblies (nanoassociates). Geochem Int. 2014;52(13):1207-26. https://doi.org/10.1134/S0016702914130072
- Linde K, Jonas WB, Melchart D, Worku F, Wagner H, Ei-tel F. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol. 1994;13(7):481-92. https://doi.org/10.1177/096032719401300706
- Makri A, Goveia M, Balbus J, Parkin R. Children's susceptibility to chemicals: a review by developmental stage. J Toxicol Environ Health, Part B. 2004;7(6):417-35. https://doi.org/10.1080/10937400490512465
- Fun with homeopaths and meta-analyses of homeopathy trials [internet]. Science Based Medicine; 2008. Available from: https://www.sciencebasedmedicine.org/contact-us/.